COMBINATION OF BIOMARKERS FOR FORECASTING A RESPONSE OR NON-RESPONSE TO AN ANTI-HCV TREATMENT

The application concerns means for predicting whether a subject infected with one or more HCVs has a high probability of responding to an anti-HCV treatment which will comprise the administration of interferon and of ribavirin or whether, in contrast, that subject has a high probability of not respo...

Full description

Saved in:
Bibliographic Details
Main Authors WATELET, Bénédicte, AFSHAR, Mohammad, MATHIEU, Eve, Laure, ASSELAH, Tarik, VIDAUD, Michel, BIECHE, Ivan, MARCELLIN, Patrick, BATXELLI, Isabelle, Catherine, JULLIAN, Nathalie
Format Patent
LanguageEnglish
French
German
Published 10.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The application concerns means for predicting whether a subject infected with one or more HCVs has a high probability of responding to an anti-HCV treatment which will comprise the administration of interferon and of ribavirin or whether, in contrast, that subject has a high probability of not responding to that anti-HCV treatment. The means of the invention in particular involve assaying the levels of expression of selected genes, said selected genes being: at least one gene from among MBL2, LGALS3BP and IL8, and at least one gene from among G1P2, CCL21 and CXCL10, and optionally, at least one gene from among AFP, CRP, CXCL11, CXCL6, CXCL9, FGF7, MDK, MMP2, SFN, TGFB2 and VEGFD.
Bibliography:Application Number: EP20120703312